Welcome! We founded MS Money Moves after coming to terms with the fact that our generation loves to spend money, generally does not save or invest, and as a result, won’t be able to retire as easily as previous generations.
After digesting this information we knew we could make an impactful societal, cultural, and economic difference through MS Money Moves. We are here to help today’s youth think about finance in a lens otherwise not taught in traditional education. Our aim is to instill inspiration and provide the tools and resources needed to realize a financial situation that you may have otherwise thought ‘out of reach’.
Did you know thousands of people move in and out of the top 1% of income earners every year? The road to 1% status is not blocked by corruption or the elite like popular culture perpetuates. Anyone can make it with the right attitude, dedication, a little intelligence, and a lot of perseverance. Others may not be as financially ambitious and that is okay. We are here to serve you too! In its current form, MS Money Moves deploys swing and day trading strategies designed to capitalize on volatility in the biopharma sector of the stock market.
The MS team is dedicated to delivering educational content in tandem with top tier stock analysis to help our subscribers make informed investment decisions. We want our generation to succeed and not fall victim to the daunting statistics.
MS Money Moves Executive Leadership Team
Zion has an international BBA from the Anderson School of Management and has corporate experience working at Hewlett Packard (HP). He has been investing for 4 years and supports his education through a swing strategy.
Sultan earned a B.S in plant science from the University of California Davis and specializes in trading and evaluating biopharma companies. He worked in crop genetics research before gravitating to equity analysis and has been a dutiful student of the stock market managing his own money for four years.
Chris graduated with his Doctor of Pharmacy from The University of Findlay. Chris applies his knowledge of pharmaceutical sciences and economics to identify undervalued companies and to evaluate clinical trials’ chances of success. His favorite areas of interest is small and mid-cap oncology and rare disease companies.
We recruit talented traders and writers on an ongoing basis that want to be a part of the MS team and contribute to forwarding our vision. We want MS Money Moves to be more than a company. We want to be a movement, and we refuse to fail. Care to join?
Let’s get this bread!